140 inhalant multi-allergen.

Ended Purchase Order Awarded Last action

Contract number
N0025921P0016
Awardee
Awarding agency
Obligated
-$2,308

Award facts

Opportunity
Contract value 0% obligated
$16,726.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Onalaska, WI 54650, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 $4,160
Supplemental Agreement for work within scope P00006 -$33,544
Supplemental Agreement for work within scope P00005 $4,039
Supplemental Agreement for work within scope P00004 · Inhalant multi-allergen $0
Supplemental Agreement for work within scope P00003 · The purpose of this bilateral modification is to (1) deobligate excess funds ($15,048.00) from clin 0001. The total funded amount for this contract is decreased… -$15,048
Exercise an Option P00002 · Inhalant multi-allergen - the purpose for this bilateral modification is to (1) exercise the option quantity two, clin 2001, (2) and update points of contact… $19,606
Exercise an Option P00001 · This bilateral modification is to (1), exercise the option year one (1), clin 1001, (2) add point of contact. $19,034
Original award $18,480

About this award

The Defense Health Agency awarded a firm fixed-price purchase order valued at $16,726.48 to Allergychoices LLC for the supply of 140 units of inhalant multi-allergen products. The contract, awarded on November 4, 2020, with an ultimate completion date of November 15, 2025, was not subject to any set-aside provisions and represents a sole-source procurement recognizing Allergychoices as the sole vendor capable of meeting the government's specialized requirements. The work will be performed in Onalaska, Wisconsin, where Allergychoices, a self-certified small disadvantaged business, is located and operates.

Allergychoices specializes in customized sublingual immunotherapy products, providing individualized allergy treatment drops designed for patients with environmental or food allergies. This purchase order is part of the company's broader engagement with the Defense Health Agency, which includes a $250,000 Blanket Purchase Agreement valid through July 31, 2028. The BPA enables the Defense Health Agency to procure specialized allergy treatments supporting medical readiness for Service members, their families, and retirees through task orders and price lists, with Allergychoices' at-home treatment option offering a convenient alternative to traditional allergy immunotherapy approaches.

Quick answers

Who was awarded contract N0025921P0016?

N0025921P0016 was awarded to Allergychoices LLC by Defense Health Agency (Department of Defense) on November 4, 2020.

How much is contract N0025921P0016 worth?

The government has obligated -$2,308 on N0025921P0016. Its current value, with exercised options, is $16,726.

Was contract N0025921P0016 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award